Martin, Jennifer H. http://orcid.org/0000-0002-8614-0199
Hill, Courtney
Walsh, Anna
Efron, Daryl
Taylor, Kaitlyn
Kennedy, Michael
Galettis, Rachel
Lightfoot, Paul
Hanson, Julie
Irving, Helen
Agar, Meera
Lacey, Judith
Funding for this research was provided by:
National Health and Medical Research Council (Centre of Research Excellence 2017-22)
Article History
Received: 13 May 2020
Accepted: 3 November 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: JH, AW, PL, KT, MK and HI declare no competing interests.Professor Meera Agar is chair of the Medical Research Ethics Committee at the University of Technology Sydney, a member of South West Sydney Human Research Ethics Committee. Professor Agar also receives NSW Government funding for clinical trials ‘Evaluation of pharmaceutical cannabinoids and standardized botanical leaf cannabis for anorexia in advanced cancer’.Professor Jennifer Martin, Dr Rachel Galettis and Courtney Hill are part of the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), which is funded through the National Health and Medical Research Council’s Centres of Research Excellence Program. ACRE also receives funding through NSW Health’s Clinical Cannabis Medicines Program, which supports Dr Galettis and Ms Hill’s roles as Clinical Trial Manager and Clinical Trial Coordinator for the CARE NSW Trial.A/Prof Judith Lacey is an <i>investigator</i> on a “Phase 2 Randomised, Double-Blind Clinical Trial Assessing the Tolerability Of Two Different Ratios Of Cannabis medicines In Patients With Glioblastoma Multiforme (GBM)”. Supported by Bioceuticals pharmaceuticals.